机译:移植相关的血栓形成微观病症:异种造血细胞移植的发病率,预后因素,发病率和死亡率
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
G Papanicolaou Hosp Nephrol Dept Thessaloniki Greece;
G Papanicolaou Hosp Hematol Dept BMT Unit Thessaloniki Greece;
allogeneic hematopoietic cell transplantation; incidence; morbidity; mortality; prognostic factors; transplant-associated thrombotic microangiopathy;
机译:移植相关的血栓形成微观病症:异种造血细胞移植的发病率,预后因素,发病率和死亡率
机译:移植相关的血栓性微血管病:血液疾病无关异体移植的患病率,预后因素和治疗结果
机译:移植相关的血栓性微血管病:血液疾病无关异体移植的患病率,预后因素和治疗结果
机译:同种异体造血细胞移植(HCT)中抑制杀伤细胞IG样受体(IKIR)匹配的影响
机译:与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
机译:小儿造血细胞移植受者中的移植相关血栓性微血管病:一种诊断和管理的实用方法。
机译:Haptoglobin降解产物作为新型血清生物标志物,用于造血干细胞移植相关血栓性微肿大